近十年来钙阻滞剂在高血压病的治疗中得到承认,而且越来越受到临床重视。我们在观察硝苯啶治疗高血压病临床疗效的同时又做了用药前后血清 T_3、T_4、T_3/T_4及ACE(血管紧张素Ⅰ转换酶)测定,结果如下:临床资料一、对象原发性高血压病住院患者15例,其中男10例,女5例。平均年龄43.7岁。其中4例合并冠心病,8例合并高血脂症。观察前检查:血、尿常规,BUN、血肌酐、血糖、肝功、GPT、血脂、TG、B-LP、T—ch 及 HDL、心电图、超声心动图及胸部 X 线检查。以除外继发性高血压及甲亢症。 Calcium blockers have been recognized in the treatment of hypertension for more than a decade and have gained more and more clinical attention. We observe the clinical efficacy of nifedipine in the treatment of hypertension while doing before and after treatment of serum T_3, T_4, T_3 / T_4 and ACE (angiotensin I converting enzyme) determination, the results are as follows: Clinical data First, the object of primary 15 cases of hospitalized patients with hypertension, including 10 males and 5 females. The average age of 43.7 years old. 4 cases of coronary heart disease, 8 cases of hyperlipidemia. Preoperative observation: blood, urine routine, BUN, serum creatinine, blood glucose, liver function, GPT, lipids, TG, B-LP, T-ch and HDL, electrocardiogram, echocardiography and chest X-ray. With the exception of secondary hypertension and hyperthyroidism.